News View Non-AMP

XRP ETF News: Institutional Demand Surges Despite Ripple vs SEC Lawsuit

Published by
Qadir AK

The U.S. Securities and Exchange Commission’s (SEC) legal battle with Ripple has been a rollercoaster ride, filled with unexpected twists and turns. However, amid all the drama, a surprising trend has emerged: institutional investors are doubling down on XRP. Recent developments suggest that big players in the financial world are not deterred by the SEC’s actions, but rather, see an opportunity in the potential of XRP.

As Ripple CEO Brad Garlinghouse hinted on X, this itself is a win for the company.

Read on to discover the latest updates on XRP ETFs and the crypto market impact.

21Shares’ XRP ETF Proposal

Leading the charge, 21Shares has applied to launch an ETF called the “21Shares Core XRP Trust.” If approved, this fund would be listed on the Cboe BZX exchange, with Coinbase Custody Trust Company acting as the custodian for its XRP assets. This proposal shows 21Shares’ confidence in XRP-focused investment products, even amid regulatory uncertainty.

New Contenders Enter the Picture

21Shares isn’t the only one in the race. Canary Capital and Bitwise are also planning XRP-based ETFs, a sign that XRP’s appeal is growing among institutional investors. Their involvement underscores broader industry support for XRP, despite the legal challenges Ripple faces.

Institutional Interest Builds Despite Regulatory Hurdles

In his post, Garlinghouse emphasized that more institutional players are looking to invest in XRP, undeterred by Ripple’s ongoing dispute with the SEC. Interestingly, three out of four recent XRP filings were submitted after the SEC appealed a federal court ruling favoring Ripple’s argument that XRP isn’t a security.

Grayscale’s Bold Plans Revealed?!

Adding further momentum, Grayscale Investments is reportedly preparing to convert its multi-asset fund, which includes XRP, into a dedicated XRP spot ETF. This move would mark a major entry into the XRP ETF market by Grayscale, likely drawing even more institutional attention to XRP.

Garlinghouse sees this trend as a win against regulatory opposition, suggesting that the SEC’s actions could ultimately hurt its reputation in the crypto industry.

What’s Next for XRP ETFs?

The growing number of XRP ETF filings shows increasing institutional confidence in XRP, even amid legal hurdles. These developments could mark a new chapter for XRP in the financial market, as institutional interest remains strong despite regulatory pushback.

Do you think the SEC’s legal battle with Ripple will impact the approval of XRP ETFs? Let us know your take.

Qadir AK

Qadir Ak is the founder of Coinpedia. He has over a decade of experience writing about technology and has been covering the blockchain and cryptocurrency space since 2010. He has also interviewed a few prominent experts within the cryptocurrency space.

Recent Posts

Where to Buy Influencer Pepe Before It Hits Major Exchanges!

A new meme coin that is gaining significant attention in the cryptocurrency market is Influencer…

March 31, 2025

Bitcoin (BTC) Drops Toward Range Lows While Whales Accumulate a New Token Priced at $0.025

While Bitcoin hovers near its recent range lows, a quiet shift is taking place in…

March 31, 2025

Dogecoin is Facing Rising Bearish Threat as It Drops Toward $0.16: Will Buyers Bounce Back?

Dogecoin has experienced a significant decline in the past few hours, facing a sharp selloff…

March 31, 2025

ICB Labs Expands Global Presence with Strategic Partnerships, Staking Opportunities, and Upcoming DEX Launch

ICB Labs continues its global expansion, strengthening its blockchain ecosystem through strategic collaborations, enhanced staking…

March 31, 2025

Best Crypto to Invest in if You Want Become A Crypto Whale: Top 3 Crypto Investments of 2025

Are you a crypto newbie who wants to become a crypto whale? If so, you've…

March 31, 2025

Remittix Raises Over $14 Million in Record Time as Presale Is Predicted to Be the Best of 2025

The crypto landscape has been stunned by the rapid success of Remittix which obtained over…

March 31, 2025